Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
This bill directs the Health and Human Services Secretary to fund research on early detection and intervention for uterine fibroids, aiming to develop evidence-based approaches for healthcare settings. It authorizes grants to states to support screening (including advanced imaging), patient navigation services, and public education campaigns focused on early detection, with priority given to areas with socially vulnerable populations at higher risk. The bill also funds research into disparities in pain management during fibroid surgery and conditions like Asherman’s Syndrome. These provisions directly affect women with uterine fibroids, particularly in underserved communities, by expanding access to early detection services and targeted research.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jul 2025
Committee Review
Floor Vote
President
Introduced Jul 15, 2025
Last action Jul 15, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Jul 15, 2025
Committee
Referred to the House Committee on Energy and Commerce.
lower
Jul 15, 2025
Introduced
Introduced in House
lower
1 primary · 54 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Shontel M. Brown
DDemocratic
Co
Al Green
DDemocratic
Co
Alma S. Adams
DDemocratic
Co
Andrea Salinas
DDemocratic
Co
Angie Craig
DDemocratic
Co
April McClain Delaney
DDemocratic
Co
Ayanna Pressley
DDemocratic
Co
Bennie G. Thompson
DDemocratic
Co
Bonnie Watson Coleman
DDemocratic
Co
Cleo Fields
DDemocratic
Co
David Scott
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 4392
Scope: US
Hi! I can help you understand HR 4392. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline